Clinical Psychopharmacology is a specialized field at the intersection of psychiatry and pharmacology, devoted to understanding the effects of psychotropic medications on mental health. This discipline plays a pivotal role in the treatment of various psychiatric disorders, offering interventions that target neurotransmitter systems to alleviate symptoms. Practitioners in clinical psychopharmacology utilize evidence-based approaches to prescribe and monitor the use of psychotropic drugs, tailoring treatments to individual patient needs. The field encompasses the study of a wide range of medications, including antidepressants, antipsychotics, anxiolytics, and mood stabilizers. Monitoring side effects and adjusting medication regimens based on individual responses are critical aspects of clinical psychopharmacology. Ethical considerations, informed consent, and a comprehensive understanding of psychopathology are integral to responsible practice in this field. The evolving landscape of neuroscience and pharmacology continually informs clinical psychopharmacology, allowing for the development of novel medications and personalized treatment approaches. Collaboration between mental health professionals, pharmacologists, and researchers is essential for advancing the field and improving outcomes for individuals grappling with mental health challenges.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary